Form 4: Trupanion CEO Margaret Tooth Reports Stock Transactions
SEC Form 4 Filing
CEO Margaret Tooth reports the vesting of restricted stock units and associated tax withholding.
Summary
- Margaret Tooth, CEO of Trupanion, Inc., reported transactions involving Trupanion's common stock.
- On August 22, 2024, 6,250 restricted stock units (RSUs) vested and converted into common stock.
- The company withheld 1,521 shares to cover income tax obligations at a price of $45.39 per share.
- Following these transactions, Tooth directly owns 92,759 shares of common stock and 37,500 RSUs.
- The RSUs were granted on February 27, 2024, and vest quarterly, with the next vesting date on November 22, 2024.
Sentiment
Score: 6
Explanation: The document reflects routine insider transactions related to executive compensation, which is neutral to slightly positive as it indicates continued alignment of management with shareholder interests.
Positives
- The vesting of RSUs indicates that the CEO is meeting the conditions of her compensation package.
- The CEO continues to hold a significant number of shares, aligning her interests with those of shareholders.
Future Outlook
The remaining RSUs will continue to vest quarterly, subject to continued service.
Industry Context
Form 4 filings are routine disclosures for publicly traded companies, providing transparency into the transactions of company insiders. This filing indicates normal compensation-related stock activity for Trupanion's CEO.
Comparison to Industry Standards
- Stock-based compensation is a common practice in the technology and healthcare industries to align executive incentives with company performance.
- Vesting schedules and RSU grants are typical components of executive compensation packages in publicly traded companies.
- Companies like Zoetis and IDEXX Laboratories, which operate in related animal health sectors, also utilize stock-based compensation for their executives.
Stakeholder Impact
- Shareholders may view the vesting of RSUs as a sign of continued commitment from the CEO.
- The transactions have a minimal direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| February 27, 2024 | Reporting person was granted 50,000 restricted stock units (RSUs). |
| May 22, 2024 | 1/8th of the total shares vested. |
| August 22, 2024 | 6,250 Restricted stock units (RSUs) vested and converted into common stock. |
| August 26, 2024 | Date of Form 4 filing. |
| November 22, 2024 | Next vesting date for 1/8th of the total shares. |
| February 22, 2026 | Expiration date of the Restricted Stock Unit (RSU). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.